Kruppel-like factor 4 (KLF4) suppresses neuroblastoma cell growth and determines non-tumorigenic lineage differentiation

被引:32
作者
Shum, C. K. Y. [1 ]
Lau, S. T. [1 ]
Tsoi, L. L. S. [1 ]
Chan, L. K. [2 ]
Yam, J. W. P. [2 ]
Ohira, M. [3 ]
Nakagawara, A. [3 ]
Tam, P. K. H. [1 ,4 ]
Ngan, E. S. W. [1 ,4 ]
机构
[1] Univ Hong Kong, Dept Surg, Pokfulam, Hong Kong, Peoples R China
[2] Univ Hong Kong, Dept Pathol, Pokfulam, Hong Kong, Peoples R China
[3] Chiba Canc Ctr, Res Inst, Chiba 2608717, Japan
[4] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Reprod Dev & Growth, Pokfulam, Hong Kong, Peoples R China
关键词
differentiation; regression; neuroblastoma; CREST STEM-CELLS; BREAST-CANCER; CHILDHOOD NEUROBLASTOMA; GENE AMPLIFICATION; PROGNOSTIC-FACTORS; SERUM FERRITIN; EXPRESSION; PROGRESSION; TUMORS; MYCN;
D O I
10.1038/onc.2012.437
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neuroblastoma (NB) is an embryonal tumor and possesses a unique propensity to exhibit either a spontaneous regression or an unrestrained growth. However, the underlying mechanism for this paradoxical clinical outcome remains largely unclear. Quantitative RT-PCR analysis on 102 primary NB tumors revealed that lower Kruppel-like factor 4 (KLF4) expression is frequently found in the unfavorable NB (Mann-Whitney test, P = 0.027). In particular with the high-risk factors such as age of patient 41 year, MYCN amplification and low TRKA expression, the decreased expression of KLF4 was significantly associated with an unfavorable NB outcome. Despite knockdown of KLF4 alone is not sufficient to increase tumorigenicity of NB cells in vivo, stable expression of KLF4 short hairpin RNA in Be(2)-C cells significantly promoted growth of NB cells and inhibited cell differentiation toward fibromuscular lineage. In concordant with these observations, overexpression of KLF4 in SH-SY-5Y cells profoundly suppressed cell proliferation by direct upregulation of cell-cycle inhibitor protein p21(WAF1/CIP1), and knocking down p21(WAF1/CIP1) could partially rescue the suppressive effect of KLF4. Importantly, KLF4 overexpressing cells have lost their neuroblastic phenotypes, they were epithelial-like, strongly substrate-adherent, expressing smooth muscle marker and became non-tumorigenic, suggesting that KLF4 expression is crucial for lineage determination of NB cells, probably, favoring spontaneous tumor regression. Subsequent global gene expression profiling further revealed that transforming growth factor beta (TGF beta) and cell-cycle pathways are highly dysregulated upon KLF4 overexpression, and myogenic modulators, MEF2A and MYOD1 were found significantly upregulated. Taken together, we have demonstrated that KLF4 contributes to the favorable disease outcome by directly mediating the growth and lineage determination of NB cells.
引用
收藏
页码:4086 / 4099
页数:14
相关论文
共 57 条
[1]   Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells [J].
Acosta, Sandra ;
Lavarino, Cinzia ;
Paris, Raquel ;
Garcia, Idoia ;
de Torres, Carmen ;
Rodriguez, Eva ;
Beleta, Helena ;
Mora, Jaume .
BMC DEVELOPMENTAL BIOLOGY, 2009, 9
[2]   KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERα [J].
Akaogi, K. ;
Nakajima, Y. ;
Ito, I. ;
Kawasaki, S. ;
Oie, S-H ;
Murayama, A. ;
Kimura, K. ;
Yanagisawa, J. .
ONCOGENE, 2009, 28 (32) :2894-2902
[3]   Topotecan blocks hypoxia-inducible factor-1α, and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells [J].
Beppu, Y ;
Nakamura, K ;
Linehan, WM ;
Rapisarda, A ;
Thiele, CJ .
CANCER RESEARCH, 2005, 65 (11) :4775-4781
[4]   Cell renewing in neuroblastoma: Electrophysiological and immunocytochemical characterization of stem cells and derivatives [J].
Biagiotti, Tiziana ;
D'Amico, Massimo ;
Marzi, Ilaria ;
Di Gennaro, Paola ;
Arcangeli, Annarosa ;
Wanke, Enzo ;
Olivotto, Massimo .
STEM CELLS, 2006, 24 (02) :443-453
[5]  
BIEDLER JL, 1978, CANCER RES, V38, P3751
[6]  
BRESLOW N, 1971, CANCER RES, V31, P2098
[7]   Trk Receptor Expression and Inhibition in Neuroblastomas [J].
Brodeur, Garrett M. ;
Minturn, Jane E. ;
Ho, Ruth ;
Simpson, Anisha M. ;
Iyer, Radhika ;
Varela, Carly R. ;
Light, Jennifer E. ;
Kolla, Venkatadri ;
Evans, Audrey E. .
CLINICAL CANCER RESEARCH, 2009, 15 (10) :3244-3250
[8]   REVISIONS OF THE INTERNATIONAL CRITERIA FOR NEUROBLASTOMA DIAGNOSIS, STAGING, AND RESPONSE TO TREATMENT [J].
BRODEUR, GM ;
PRITCHARD, J ;
BERTHOLD, F ;
CARLSEN, NLT ;
CASTEL, V ;
CASTLEBERRY, RP ;
DEBERNARDI, B ;
EVANS, AE ;
FAVROT, M ;
HEDBORG, F ;
KANEKO, M ;
KEMSHEAD, J ;
LAMPERT, F ;
LEE, REJ ;
LOOK, AT ;
PEARSON, ADJ ;
PHILIP, T ;
ROALD, B ;
SAWADA, T ;
SEEGER, RC ;
TSUCHIDA, Y ;
VOUTE, PA .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (08) :1466-1477
[9]   BMPs functionally replace Klf4 and support efficient reprogramming of mouse fibroblasts by Oct4 alone [J].
Chen, Jiekai ;
Liu, Jing ;
Yang, Jiaqi ;
Chen, You ;
Chen, Jing ;
Ni, Su ;
Song, Hong ;
Zeng, Lingwen ;
Ding, Ke ;
Pei, Duanqing .
CELL RESEARCH, 2011, 21 (01) :205-212
[10]   RhoA modulates smad signaling during transforming growth factor-β-induced smooth muscle differentiation [J].
Chen, SY ;
Crawford, M ;
Day, RM ;
Briones, VR ;
Leader, JE ;
Jose, PA ;
Lechleider, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (03) :1765-1770